Mertens, Fredrik
Pathology,
Sweden
2025 Rank: 94488
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 3679 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 94488 | 97238 |
| Total Cites | 21456 | 24388 |
| H-index | 75 | 83 |
| Hm-index | 27 | 29 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 58 | 58 |
| Total Cites to Single+First Authored Papers | 2660 | 2988 |
| Number of Single+First+Last Authored Papers | 171 | 171 |
| Total Cites to Single+First+Last Authored Papers | 7568 | 8529 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 15259 | 16254 |
| Ratio of Total Citations to Distinct Citing Papers | 1.41 | 1.50 |
| Self-Citation Percentage |
12.02%
|
|
Mertens, Fredrik
Lunds Universitet,
Sweden
2024 Rank: 90595
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 3579 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 90595 | 93933 |
| Total Cites | 20275 | 23079 |
| H-index | 73 | 80 |
| Hm-index | 26 | 28 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 58 | 58 |
| Total Cites to Single+First Authored Papers | 2544 | 2866 |
| Number of Single+First+Last Authored Papers | 167 | 167 |
| Total Cites to Single+First+Last Authored Papers | 7105 | 8013 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 14401 | 15358 |
| Ratio of Total Citations to Distinct Citing Papers | 1.41 | 1.50 |
| Self-Citation Percentage |
12.15%
|
|
Mertens, Fredrik
Institutionen för laboratoriemedicin,
Sweden
2023 Rank: 86335
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 3485 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 86335 | 90027 |
| Total Cites | 19184 | 21919 |
| H-index | 72 | 79 |
| Hm-index | 26 | 27 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 58 | 58 |
| Total Cites to Single+First Authored Papers | 2452 | 2766 |
| Number of Single+First+Last Authored Papers | 165 | 165 |
| Total Cites to Single+First+Last Authored Papers | 6693 | 7584 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 13606 | 14539 |
| Ratio of Total Citations to Distinct Citing Papers | 1.41 | 1.51 |
| Self-Citation Percentage |
12.48%
|
|
Mertens, Fredrik
Institutionen för laboratoriemedicin,
Sweden
2022 Rank: 86430
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 3472 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 86430 | 86844 |
| Total Cites | 17597 | 20208 |
| H-index | 66 | 75 |
| Hm-index | 25 | 27 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 58 | 58 |
| Total Cites to Single+First Authored Papers | 2283 | 2588 |
| Number of Single+First+Last Authored Papers | 162 | 162 |
| Total Cites to Single+First+Last Authored Papers | 6068 | 6909 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 12620 | 13515 |
| Ratio of Total Citations to Distinct Citing Papers | 1.39 | 1.50 |
| Self-Citation Percentage |
12.92%
|
|
Mertens, Fredrik
Institutionen för laboratoriemedicin,
Sweden
2021 Rank: 84224
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 3403 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 84224 | 84938 |
| Total Cites | 16876 | 19449 |
| H-index | 65 | 73 |
| Hm-index | 24 | 26 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 58 | 58 |
| Total Cites to Single+First Authored Papers | 2192 | 2495 |
| Number of Single+First+Last Authored Papers | 161 | 161 |
| Total Cites to Single+First+Last Authored Papers | 5800 | 6631 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 12181 | 13050 |
| Ratio of Total Citations to Distinct Citing Papers | 1.39 | 1.49 |
| Self-Citation Percentage |
13.23%
|
|
Mertens, Fredrik
Lunds Universitet,
Sweden
2020 Rank: 78551
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 3349 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 78551 | 79233 |
| Total Cites | 15578 | 18076 |
| H-index | 63 | 71 |
| Hm-index | 24 | 26 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 57 | 57 |
| Total Cites to Single+First Authored Papers | 2034 | 2331 |
| Number of Single+First+Last Authored Papers | 156 | 156 |
| Total Cites to Single+First+Last Authored Papers | 5240 | 6039 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 11230 | 12070 |
| Ratio of Total Citations to Distinct Citing Papers | 1.39 | 1.50 |
| Self-Citation Percentage |
13.82%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.